Novotech White Papers

31. Global Outlook Of Multi-Specific Monoclonal Antibodies: Asia Pacific Focus 5/9/2023

    Learn about the global clinical trial landscape of multi-specific monoclonal antibodies (Mabs), with emphasis on trends in the Asia Pacific, and recent advancements in the field.

32. Capitalize On Regulatory Expertise To Simplify FDA Complexities 5/9/2023

    Get an overview of the global approval landscape, pathways to approval, and the importance of a robust clinical development program as made possible with the help of an experienced CRO.

33. Antibody Drug Conjugates: Global Trial Landscape - Focus On Asia Pacific 5/9/2023

    Gain a better understanding of the global clinical trial landscape of antibody drug conjugates (ADCs) and their trends in the Asia Pacific.

34. C3 Glomerulopathy: The Asia Pacific Clinical Trial Landscape 1/6/2023

    C3 Glomerulopathy (C3G) is a complex, rare complement-mediated renal disease. Find out its effects in the Asia Pacific.

35. Diabetic Retinopathy: The Asia Pacific Clinical Trial Landscape 1/6/2023

    Diabetic Retinopathy (DR) is the leading cause of vision loss in working-age populations, and one of the main complications of Diabetes Mellitus (DM). Read about the effects of this disease.

36. Opportunities For Ophthalmology Clinical Development In APAC: Glaucoma 1/6/2023

    The world is heavily burdened by glaucoma, which is the second-leading cause of blindness and the primary cause of irreversible blindness. Learn about its effects in the Asia Pacific.

37. Peanut Allergy: Asia Pacific Clinical Trial Landscape 1/6/2023

    Explore the differences between the common food allergies in Asia and the West, specifically the peanut allergy.

38. Paroxysmal Nocturnal HemoglobinuriaIn: The Asia Pacific Clinical Trial Landscape 1/6/2023

    Paroxysmal nocturnal hemoglobinuria (PNH) is a rare condition that affects the ability of hematopoietic stem cells and their cellular offspring to bind specific proteins to the cell surface.

39. Top Therapeutic Areas In The Asia Pacific Clinical Trial Landscape 1/6/2023

    Explore why the Asia-Pacific region has emerged as a clinical trial hub due to the ease of regulatory compliance, low trial costs, rising patient population, and the availability of top clinical institutions as trial locations

40. Cell & Gene Therapy In The Asia Pacific Clinical Trial Landscape 1/6/2023

    Discover how a new class of therapeutics called cell and gene therapies are revolutionizing how diseases are treated and even potentially cured.